# | Blank 1 | Frequency | Blank 2 | Frequency | Blank 3 | Frequency | |
---|---|---|---|---|---|---|---|
1 | 5 | subjects with | 7 | drug | 19 | 12 | |
2 | 3 | have evidence of | 4 | treatment | 2 | or active noninfectious pneumonitis . | 3 |
3 | 9 | 4 | NA | . | 2 | ||
4 | 10 | patients with | 3 | NA | in the opinion of the treating investigator | 1 | |
5 | 1 | patients must not have known | 1 | NA | prior therapy | 1 | |
6 | 2 | no patients with | 1 | NA | or active noninfectious pneumonitis | 1 | |
7 | 4 | participants with | 1 | NA | note subjects must have baseline oxygen / saturation level requirements as above | 1 |